Biotechnology Reagents & Kits Market Scope
The increasing investment in research and development by prominent biotech businesses, as well as the widespread use of molecular biology, are driving the market's expansion. Biotechnology reagents are substances that are used to identify another substance, such as a virus, bacteria, fungal, or parasite, in order to get a test result. In the fields of research, diagnosis, bioscience, and teaching, these reagents and test kits are employed. The expansion of the biotechnology reagent and kit market is aided by government and pharmaceutical industry technical investments. Furthermore, due to breakthroughs and technological advancements in genetic engineering, large data analysis and storage, as well as gene therapy, the subject of genomic sequencing is gaining increasing attention.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
High Growth Market | Asia Pacific |
Largest Market | North America |
Unit | Value (USD Million) |
Key Companies Profiled | Agilent Technologies, Inc. (United States), Bio-Rad Laboratories (United States), F. Hoffmann-La Roche Ltd. (Switzeland), Merck KGaA (United States), Promega Corp. (United States), Thermo Fisher Scientific (United States), QIAGEN (Germany), Takara Bio, Inc.(Japan), LGC Ltd.(United Kingdom) and Toyobo Co. Ltd. (Japan) |
CAGR | 17.02% |
With a large number of competitors, the Biotechnology Reagents & Kits market is extremely competitive. In the near future, the market for biotechnology reagents and kits is expected to grow significantly. The market has become more competitive as the number of technological collaborations among working units has increased, as has their product range. The big companies' commitment to the development of new equipment/products has a positive impact on market expansion and increases their competitiveness within the market. Biotechnology firms are stepping up their efforts to combat the spread of the Covid-19 pandemic. Additionally, this has created chances for organizations that are attempting to get a larger market share by capitalizing on previously untapped potential. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Biotechnology Reagents & Kits market throughout the predicted period.
Agilent Technologies, Inc. (United States), Bio-Rad Laboratories (United States), F. Hoffmann-La Roche Ltd. (Switzeland), Merck KGaA (United States), Promega Corp. (United States), Thermo Fisher Scientific (United States), QIAGEN (Germany), Takara Bio, Inc.(Japan), LGC Ltd.(United Kingdom) and Toyobo Co. Ltd. (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are New England Biolabs (United States) and Illumina, Inc. (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Biotechnology Reagents & Kits market by Type and Region with country level break-up.
On the basis of geography, the market of Biotechnology Reagents & Kits has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2021. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.
Market Leaders and their expansionary development strategies
1 December 2021 - Roche has announced it has completed its share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group. TIB Molbiol will continue to operate as a subsidiary within the Diagnostics division.
In December 2020, Stilla Technologies, a biotech firm based in Europe, has introduced the naica multiplex PCR MIX and naica PCR MIX ready-to-use solutions, which are optimized for performance and resilience in digital PCR applications. and In May 2020, CARTANA, a Swedish biotechnology company, has released a new line of In Situ Sequencing (ISS) reagent kits that are meant to boost efficiency and allow ISS on nearly any tissue sample.
Influencing Trend:
Biopharmaceuticals are gaining popularity., Due to technological advancements in the field of biotechnology, there is a lot of demand., The use of molecular biology is becoming more common. and Environmental applications are becoming more prevalent.
Market Growth Drivers:
Biotechnology companies spend a lot of money on research and development., Increasing demand for synthetic biology as the number of biotechnology companies grows. and Stem cell research has resulted in a surge in demand.
Challenges:
Stringent Government Regulations for Approval of Reagents
Restraints:
The high price of biopharmaceuticals
Opportunities:
Biotechnology businesses' increased R&D investment and During the early stages of the pandemic, there was a global shortage of nucleic acid isolation and purification kits due to the high demand.
Analyst View
The development of many analytical tests, which are employed for Covid-19, has also aided the market's growth. The use of a flow cytometry-based approach for Covid-19 study has been advocated in new research. Furthermore, the researchers used the approach to identify the type of T cells involved in the Covid-19 resistance reaction. This has resulted in increased demand for flow cytometry reagents and kits, resulting in market expansion. A number of techniques and engineering tools have been developed in response to increased market demand as a result of recent advancements in the molecular biology sector. Increasing research funding in molecular biology has accelerated the usage of biotechnology reagents and kits in recent years.
Key Target Audience
Biotechnology Reagents & Kits Providers, Government Regulatory Bodies, Private Research Organizations, Government research Organizations and Others